Found: 77
Select item for more details and to access through your institution.
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.
- Published in:
- BJU International, 2012, v. 110, n. 6, p. 840, doi. 10.1111/j.1464-410X.2011.10922.x
- By:
- Publication type:
- Article
Evaluation of Trends in Treatment of Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Across Canada During the COVID-19 Pandemic.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 2, p. 273, doi. 10.1016/j.clgc.2022.11.020
- By:
- Publication type:
- Article
Comprehensive genomic profiling of treatment resistant metastatic castrate sensitive prostate cancer reveals high frequency of potential therapeutic targets.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 3, p. 278, doi. 10.1016/j.clgc.2022.02.004
- By:
- Publication type:
- Article
Neoadjuvant Versus Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Microsimulation Model.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 2, p. e135, doi. 10.1016/j.clgc.2020.10.001
- By:
- Publication type:
- Article
Lack of Evidence Does Not Equal Lack of Benefit: Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Transitioning to a New Normal in the Post-COVID Era.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 7, p. 1, doi. 10.1007/s11912-020-00956-1
- By:
- Publication type:
- Article
Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 2, p. 1, doi. 10.1007/s11912-020-0880-5
- By:
- Publication type:
- Article
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer.
- Published in:
- Radiation Oncology, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13014-023-02338-w
- By:
- Publication type:
- Article
Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 7, p. 1, doi. 10.1007/s00520-023-07870-9
- By:
- Publication type:
- Article
Clinical trial reform in the post-COVID era.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231183676
- By:
- Publication type:
- Article
The prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma treated with first-line platinum-based chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221094879
- By:
- Publication type:
- Article
Prime time for immunotherapy in advanced urothelial cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, p. 24, doi. 10.1111/ajco.13059
- By:
- Publication type:
- Article
Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2012, v. 18, n. 2, p. 311, doi. 10.1177/1078155211429384
- By:
- Publication type:
- Article
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 5, p. 1005, doi. 10.1007/s10637-014-0106-5
- By:
- Publication type:
- Article
Metastatic Urothelial Cancer: a rapidly changing treatment landscape.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211047352
- By:
- Publication type:
- Article
Metastatic Urothelial Cancer: a rapidly changing treatment landscape.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211047352
- By:
- Publication type:
- Article
Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0166-y
- By:
- Publication type:
- Article
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study.
- Published in:
- PLoS ONE, 2021, v. 16, n. 12, p. 1, doi. 10.1371/journal.pone.0259272
- By:
- Publication type:
- Article
Identification of characteristics predictive of long-term survival with durvalumab or durvalumab plus tremelimumab in metastatic urothelial carcinoma.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11380-6
- By:
- Publication type:
- Article
A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 4, p. 1008, doi. 10.1007/s10637-013-9931-1
- By:
- Publication type:
- Article
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 5, p. 1045, doi. 10.1007/s10637-010-9408-4
- By:
- Publication type:
- Article
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 1, p. 159, doi. 10.1007/s10549-017-4580-2
- By:
- Publication type:
- Article
Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration‐resistant prostate cancer treated with Radium‐223.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 17, p. 5775, doi. 10.1002/cam4.4125
- By:
- Publication type:
- Article
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Tolerability of Lapatinib in the Management of Breast Cancer.
- Published in:
- Breast Cancer: Basic & Clinical Research, 2012, n. 6, p. 67, doi. 10.4137/BCBCR.S6374
- By:
- Publication type:
- Article
Enfortumab Vedotin in urothelial cancer.
- Published in:
- Therapeutic Advances in Urology, 2020, v. 12, p. 1, doi. 10.1177/1756287220980192
- By:
- Publication type:
- Article
Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Study of Testosterone-Guided Androgen Deprivation Therapy in Management of Prostate Cancer.
- Published in:
- Prostate, 2016, v. 76, n. 2, p. 235, doi. 10.1002/pros.23117
- By:
- Publication type:
- Article
Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone.
- Published in:
- Prostate, 2014, v. 74, n. 14, p. 1462, doi. 10.1002/pros.22861
- By:
- Publication type:
- Article
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 927, doi. 10.1007/s00280-010-1389-7
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.
- Published in:
- BJU International, 2021, v. 128, n. 1, p. 79, doi. 10.1111/bju.15289
- By:
- Publication type:
- Article
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
- Published in:
- BJU International, 2021, v. 127, n. 5, p. 528, doi. 10.1111/bju.15253
- By:
- Publication type:
- Article
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
- Published in:
- BJU International, 2014, v. 113, n. 5b, p. E137, doi. 10.1111/bju.12564
- By:
- Publication type:
- Article
The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 10, p. 1888, doi. 10.1038/s41416-023-02166-5
- By:
- Publication type:
- Article
Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
- Published in:
- World Journal of Urology, 2022, v. 40, n. 11, p. 2707, doi. 10.1007/s00345-022-04160-7
- By:
- Publication type:
- Article
The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience.
- Published in:
- Journal of Kidney Cancer & VHL, 2024, v. 11, n. 1, p. 41, doi. 10.15586/jkcvhl.v11i1.307
- By:
- Publication type:
- Article
Long-term Safety of Avelumab First-line Maintenance for Advanced Urothelial Carcinoma in the JAVELIN Bladder 100 Trial.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 358
- By:
- Publication type:
- Article
Clinical Outcomes and Cost-effectiveness of Primary Prophylaxis of Febrile Neutropenia During Adjuvant Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer.
- Published in:
- Breast Journal, 2015, v. 21, n. 6, p. 658, doi. 10.1111/tbj.12501
- By:
- Publication type:
- Article
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Rapidly Evolving Landscape of First‐Line Targeted Therapy in Metastatic Urothelial Cancer: A Systematic Review.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. e1381, doi. 10.1002/onco.13827
- By:
- Publication type:
- Article
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration‐Resistant Prostate Cancer (mCRPC).
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1188, doi. 10.1634/theoncologist.2018-0621
- By:
- Publication type:
- Article
Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 12, p. 1351, doi. 10.1634/theoncologist.2015-0220
- By:
- Publication type:
- Article
A Case of Small Bowel Obstruction Due to Intraluminal Metastases from Metastatic Renal Cell Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 2, p. 95, doi. 10.1634/theoncologist.2006-0214
- By:
- Publication type:
- Article
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of age at diagnosis of de novo metastatic prostate cancer on survival.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 1, p. 21, doi. 10.1007/s40487-020-00135-z
- By:
- Publication type:
- Article
Health-Related Quality of Life in Cancer Patients—More Answers but Many Questions Remain.
- Published in:
- 2009
- By:
- Publication type:
- Editorial